Merck & Co Inc
NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024
MRK Articles
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Published:
Last Updated:
Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck and Visa.
Published:
Last Updated:
Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the index has made since the Trump rally began and push it even further beyond 20,000.
Published:
Last Updated:
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
Published:
Last Updated:
GE, Merck, Boeing, and Exxon Mobil lead the DJIA to a small loss on Monday.
Published:
Last Updated:
Merck, P&G, IBM, and Exxon Mobil lift DJIA by more than 75 points on Friday.
Published:
Last Updated:
Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.
Published:
Last Updated:
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
Published:
Last Updated:
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
Published:
Last Updated:
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
Published:
Last Updated:
The the top analyst upgrades, downgrades and initiations on Thursday include AK Steel, Merck, Twitter, U.S. Steel, Walt Disney and Xerox.
Published:
Last Updated:
Merck, Intel, IBM, Goldman Sachs lead Dow Jones Industrial Average higher Wednesday.
Published:
Last Updated:
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight move. Although...
Published:
Last Updated:
The DJIA bull-bear projection of 21,422 would be short of the preliminary look of 22,000 seen at the end of December, but another 8.4% gain likely would be more than welcome.
Published:
Last Updated: